Application no. and date | 17716763.2 (espacenet) (Federated) (European Patent Register), 20170331 | Patent/reg. no. and date | DK/EP 3436446, 20230607 | Publication date | 20190206 | Priority no. and date | US 201662316043 P, 20160331 | EP pub. no. and date |
EP 3436446 20190206 | Effective date | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Applicant ref. no. | | Inventor | BEAR, Brian, 50 Northern Avenue
Boston MA 02210, US, CLEMENS, Jeremy, 50 Northern Avenue
Boston MA 02210, US, CLEVELAND, Thomas, 50 Northern Avenue
Boston MA 02210, US, COON, Timothy, Richard, 50 Northern Avenue
Boston MA 02210, US, GROOTENHUIS, Peter, Diederik Jan, 50 Northern Avenue
Boston MA 02210, US, FRIEMAN, Bryan, A., 50 Northern Avenue
Boston MA 02210, US, HADIDA RUAH, Sara S., 50 Northern Avenue
Boston MA 02210, US, KHATUYA, Haripada, 50 Northern Avenue
Boston MA 02210, US, KRENITSKY, Paul, J., 50 Northern Avenue
Boston MA 02210, US, MILLER, Mark, Thomas, 50 Northern Avenue
Boston MA 02210, US, SILINA, Alina, 50 Northern Avenue
Boston MA 02210, US, UY, Johnny, 50 Northern Avenue
Boston MA 02210, US, ZHOU, Jinglan, 50 Northern Avenue
Boston MA 02210, US | Representative | | Opponent | | IPC Class | A61K 31/44 (2006.01) , A61P 11/00 (2006.01) , C07D 213/82 (2006.01) , C07D 401/14 (2006.01) | Title | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Int. application no. | US2017025381 | Int. publication no. | WO2017173274 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|